Afya Ltd
NASDAQ:AFYA
Afya Ltd
Afya Ltd. is an intriguing player in the education and healthcare sectors of Brazil, carving its niche in the market by providing educational services to medical students and professionals. Founded in 2017, the company's journey began with a mission to tackle the chronic shortage of qualified healthcare professionals in the country. Through a series of strategic acquisitions, Afya rapidly expanded its portfolio of medical schools and associated educational programs, becoming the preeminent provider of medical courses in Brazil. The company's growth is anchored in its distinctive hybrid business model that blends traditional brick-and-mortar educational institutions with a dynamic digital learning platform, thereby ensuring comprehensive learning experiences for aspiring medical professionals.
Revenue generation for Afya rests on its ability to enroll students into its extensive array of undergraduate and graduate medical programs, as well as continuing education courses that are mandated for medical professionals in Brazil. By leveraging economies of scale, Afya manages to run these programs efficiently, resulting in robust financial performance. The company makes money primarily through tuition fees, which are supplemented by its digital offerings, catering to a broader array of healthcare education needs. Through its digital platform, Afya not only enhances accessibility to its educational content but also taps into the growing demand for online learning solutions. This dual-channel approach enables Afya to remain agile in a rapidly evolving educational landscape while reinforcing its commitment to improving Brazil's healthcare by shaping the next generation of medical professionals.
Afya Ltd. is an intriguing player in the education and healthcare sectors of Brazil, carving its niche in the market by providing educational services to medical students and professionals. Founded in 2017, the company's journey began with a mission to tackle the chronic shortage of qualified healthcare professionals in the country. Through a series of strategic acquisitions, Afya rapidly expanded its portfolio of medical schools and associated educational programs, becoming the preeminent provider of medical courses in Brazil. The company's growth is anchored in its distinctive hybrid business model that blends traditional brick-and-mortar educational institutions with a dynamic digital learning platform, thereby ensuring comprehensive learning experiences for aspiring medical professionals.
Revenue generation for Afya rests on its ability to enroll students into its extensive array of undergraduate and graduate medical programs, as well as continuing education courses that are mandated for medical professionals in Brazil. By leveraging economies of scale, Afya manages to run these programs efficiently, resulting in robust financial performance. The company makes money primarily through tuition fees, which are supplemented by its digital offerings, catering to a broader array of healthcare education needs. Through its digital platform, Afya not only enhances accessibility to its educational content but also taps into the growing demand for online learning solutions. This dual-channel approach enables Afya to remain agile in a rapidly evolving educational landscape while reinforcing its commitment to improving Brazil's healthcare by shaping the next generation of medical professionals.
Results: Revenue for the 12‑month period was BRL 3.697 billion, in line with guidance; adjusted EBITDA was BRL 1.680 billion and adjusted EBITDA margin reached 45.4%.
Profit & Cash: Net income was BRL 768.4 million (up 18% YoY) and operating cash flow was BRL 1.548 billion (up 6%), with free cash flow of BRL 1,056 million and a 13.3% FCF yield for 2025.
Guidance: 2026 revenue guidance BRL 3.95–4.10 billion and adjusted EBITDA guidance BRL 1.7–1.8 billion; CapEx guidance BRL 340–380 million.
Capital returns: Board approved BRL 307.4 million cash dividend (BRL 3.45/share, 40% of 2025 net income) payable April 6, 2026, plus ongoing buyback program (~60% of authorization remains).
Operational trends: Undergraduate cohort >25,000 students (up 5% YoY) and 3,755 approved medical seats; continuing education revenue BRL 284 million (up ~11% YoY); Medical Practice Solutions revenue BRL 171 million (up 6%).
Strategy & investment: Management plans multi‑year investments in product integration, technology and data to deepen physician engagement and support B2B monetization; expect these investments to pressure near‑term margins.
Regulatory/Risk: Management does not expect a material 2026 impact from the new evaluation process (named); running simulations and remediation to improve outcomes for later cycles.
